» Articles » PMID: 33711441

Development of an a Priori Computational Approach for Brain Uptake of Compounds in an Insect Model System

Overview
Specialty Biochemistry
Date 2021 Mar 12
PMID 33711441
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Delivery of compounds to the brain is critical for the development of effective treatment therapies of multiple central nervous system diseases. Recently a novel insect-based brain uptake model was published utilizing a locust brain ex vivo system. The goal of our study was to develop a priori, in silico cheminformatic models to describe brain uptake in this insect model, as well as evaluate the predictive ability. The machine learning program Orange® was used to evaluate several machine learning (ML) models on a published data set of 25 known drugs, with in vitro data generated by a single laboratory group to reduce inherent inter-laboratory variability. The ML models included in this study were linear regression (LR), support vector machines (SVN), k-nearest neighbor (kNN) and neural nets (NN). The quantitative structure-property relationship models were able to correlate experimental logCtot (concentration of compound in brain) and predicted brain uptake of r > 0.5, with the descriptors log(P*MW) and hydrogen bond donor used in LR, SVN and KNN, while log(P*MW) and total polar surface area (TPSA) descriptors used in the NN models. Our results indicate that the locust insect model is amenable to data mining chemoinformatics and in silico model development in CNS drug discovery pipelines.

Citing Articles

Opportunities and challenges in application of artificial intelligence in pharmacology.

Kumar M, Nguyen T, Kaur J, Singh T, Soni D, Singh R Pharmacol Rep. 2023; 75(1):3-18.

PMID: 36624355 PMC: 9838466. DOI: 10.1007/s43440-022-00445-1.


Identification of Potential Insect Growth Inhibitor against : A Bioinformatics Approach.

Da Costa G, Neto M, Da Silva A, De Sa E, Cancela L, Vega J Int J Mol Sci. 2022; 23(15).

PMID: 35897792 PMC: 9332482. DOI: 10.3390/ijms23158218.


Looking at Developmental Neurotoxicity Testing from the Perspective of an Invertebrate Embryo.

Bicker G Int J Mol Sci. 2022; 23(3).

PMID: 35163796 PMC: 8836978. DOI: 10.3390/ijms23031871.


The Mitochondrial mitoNEET Ligand NL-1 Is Protective in a Murine Model of Transient Cerebral Ischemic Stroke.

Saralkar P, Mdzinarishvili A, Arsiwala T, Lee Y, Sullivan P, Pinti M Pharm Res. 2021; 38(5):803-817.

PMID: 33982226 PMC: 8298128. DOI: 10.1007/s11095-021-03046-4.

References
1.
Geldenhuys W, Lockman P, Philip A, McAfee J, Miller B, McCurdy C . Inhibition of choline uptake by N-cyclohexylcholine, a high affinity ligand for the choline transporter at the blood-brain barrier. J Drug Target. 2005; 13(4):259-66. DOI: 10.1080/10611860500139222. View

2.
Abbott N, Patabendige A, Dolman D, Yusof S, Begley D . Structure and function of the blood-brain barrier. Neurobiol Dis. 2009; 37(1):13-25. DOI: 10.1016/j.nbd.2009.07.030. View

3.
Pardridge W . Blood-brain barrier delivery. Drug Discov Today. 2007; 12(1-2):54-61. DOI: 10.1016/j.drudis.2006.10.013. View

4.
Geldenhuys W, Mohammad A, Adkins C, Lockman P . Molecular determinants of blood-brain barrier permeation. Ther Deliv. 2015; 6(8):961-71. PMC: 4675962. DOI: 10.4155/tde.15.32. View

5.
Kortagere S, Chekmarev D, Welsh W, Ekins S . New predictive models for blood-brain barrier permeability of drug-like molecules. Pharm Res. 2008; 25(8):1836-45. PMC: 2803117. DOI: 10.1007/s11095-008-9584-5. View